ThinkEquity Downgrades Par Pharmaceutical (PRX) to Hold
Tweet
Share
E-mailGet Alerts PRX Hot Sheet
Price: $49.98 --0%
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Join SI Premium – FREE
ThinkEquity downgraded Par Pharmaceutical (NYSE: PRX) from Buy to Hold with a price target of $50.00. The downgrade comes after this week's buyout deal.
For an analyst ratings summary and ratings history on Par Pharmaceutical click here. For more ratings news on Par Pharmaceutical click here.
Shares of Par Pharmaceutical closed at $50.05 yesterday.
For an analyst ratings summary and ratings history on Par Pharmaceutical click here. For more ratings news on Par Pharmaceutical click here.
Shares of Par Pharmaceutical closed at $50.05 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Introducing ToqanClaw: Build Any Business Tool From a Single Conversation
- Evercore ISI Downgrades Darden Restaurants (DRI) to In Line
- JPMorgan Downgrades Metcash Ltd. (MTS:AU) (MHTLY) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
